14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.71 $3.40 Wednesday, 24th Apr 2024 ESPR stock ended at $2.13. This is 1.91% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.85% from a day low at $2.06 to a day high of $2.16.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Mar 25, 2021 $26.60 $28.20 $26.24 $28.06 454 203
Mar 24, 2021 $28.29 $28.56 $26.68 $26.94 669 020
Mar 23, 2021 $29.30 $30.02 $28.04 $28.29 457 966
Mar 22, 2021 $29.81 $30.46 $29.00 $29.67 305 707
Mar 19, 2021 $28.21 $29.67 $27.93 $29.39 1 259 638
Mar 18, 2021 $29.71 $30.34 $28.25 $28.33 550 415
Mar 17, 2021 $28.95 $30.41 $28.52 $30.10 536 433
Mar 16, 2021 $31.12 $32.00 $28.95 $29.35 509 795
Mar 15, 2021 $30.51 $31.25 $29.82 $30.99 386 924
Mar 12, 2021 $29.22 $30.58 $29.16 $30.34 419 714
Mar 11, 2021 $30.50 $30.67 $29.05 $29.39 547 251
Mar 10, 2021 $30.41 $30.80 $29.25 $30.21 500 252
Mar 09, 2021 $29.50 $31.45 $29.50 $30.06 586 750
Mar 08, 2021 $29.13 $30.49 $28.33 $29.22 640 137
Mar 05, 2021 $27.90 $29.34 $27.18 $29.04 804 072
Mar 04, 2021 $27.49 $27.95 $26.08 $27.46 678 031
Mar 03, 2021 $27.51 $28.37 $27.26 $27.49 456 387
Mar 02, 2021 $28.53 $28.97 $27.60 $27.76 700 653
Mar 01, 2021 $28.41 $28.72 $27.50 $28.52 678 993
Feb 26, 2021 $27.89 $28.24 $26.23 $27.39 699 140
Feb 25, 2021 $28.70 $29.70 $27.38 $27.68 555 446
Feb 24, 2021 $29.15 $30.31 $27.55 $28.55 793 508
Feb 23, 2021 $28.60 $29.00 $27.40 $27.88 818 175
Feb 22, 2021 $29.27 $30.39 $28.50 $28.60 556 449
Feb 19, 2021 $30.27 $31.71 $29.38 $29.55 916 463
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT